Canakinumab in a subgroup of patients with COVID-19.
Ucciferri C, Auricchio A, Di Nicola M, Potere N, Abbate A, Cipollone F, Vecchiet J, Falasca K.
Ucciferri C, et al. Among authors: potere n.
Lancet Rheumatol. 2020 Aug;2(8):e457-ee458. doi: 10.1016/S2665-9913(20)30167-3. Epub 2020 Jun 4.
Lancet Rheumatol. 2020.
PMID: 32835251
Free PMC article.
No abstract available.